Home » Topics » Regulatory » Patents

Patents
RSS

A novel mechanism for inhibiting HIV infection using fibronectin fragments

Sep. 27, 1996

Anti-HIV research continues at Boehringer Ingelheim

Sep. 27, 1996

Anti-HIV bicyclic phosphoramides from DuPont Merck

Sep. 27, 1996

Lilly's newest antipicornavirus agents

Sep. 27, 1996

Takeda discloses anti-Ureaplasma agents

Sep. 27, 1996

Bayer claims naphthyridine derivatives

Sep. 27, 1996

Sanofi reports tachykinin antagonists

Sep. 27, 1996

New tocolytics from Merck & Co.

Sep. 20, 1996

Another new use claimed for raloxifene

Sep. 20, 1996

Tulane U. investigates GHRH agonists

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...